Universitätsspital Basel
4 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded under 3 name spellings.
0
Ending by 2030
Apr 2033
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Feb 8, 2027The maintenance fee for LSD Dose Identification (US 11,717,517) comes due Feb 8, 2027. Unpaid by Aug 9, 2027, it lapses early.
- 1 fee due Apr 30, 2027The maintenance fee for Antidepressant-psilocybin co-treatment to assist psychotherapy (US 11,801,256) comes due Apr 30, 2027. Unpaid by Nov 1, 2027, it lapses early.
- 2 fees due Jun 24 to 30, 2027 · next Jun 24
- 1 fee due Sep 17, 2027The maintenance fee for Carbohydrate-Glycolipid Conjugate Vaccines (US 10,588,962) comes due Sep 17, 2027. Unpaid by Mar 17, 2028, it lapses early.
- 2 fees due Oct 16 to 23, 2027 · next Oct 16
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,588,962 | Carbohydrate-Glycolipid Conjugate Vaccines In force · High confidence | In force | High confidence | |
| US 10,188,499 | Artificial vascular graft In force · USPTO record | In force | USPTO record | |
| US 11,033,642 | Multidentate bifunctional chelating agents for radionuclide complexation in diagnostics and therapy In force · USPTO record | In force | USPTO record | |
| US 11,648,103 | Artificial Vascular Graft In force · Medium confidence | In force | Medium confidence | |
| US 10,513,585 | Amphiphilic polymer systems In force · USPTO record | In force | USPTO record | |
| US 12,543,958 | Devices and Methods for Determining Heart Function of a Living Subject In force · Medium confidence | In force | Medium confidence | |
| US 10,517,509 | Assessment of the lung parenchyma by means of magnetic resonance images In force · USPTO record | In force | USPTO record | |
| US 11,364,221 | MDMA treatment to enhance acute emotional effects profile of LSD, psilocybin or other psychedelics In force · USPTO record | In force | USPTO record | |
| US 11,963,946 | Mdma Treatment to Enhance Acute Emotional Effects Profile of LSD, Psilocybin, or Other Psychedelics In force · Medium confidence | In force | Medium confidence | |
| US 11,717,517 | LSD Dose Identification In force · High confidence | In force | High confidence |
Also on record, not counted in the 13: 4 patents in force now held by others · 4 lapsed for an unpaid fee. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
3 pending · 8 abandoned · 19 no status recorded